143 related articles for article (PubMed ID: 20693981)
21. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
[TBL] [Abstract][Full Text] [Related]
22. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
[TBL] [Abstract][Full Text] [Related]
23. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study.
Klein R; Roggendorf W
Acta Neuropathol; 2001 Mar; 101(3):245-8. PubMed ID: 11307624
[TBL] [Abstract][Full Text] [Related]
24. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
Reuss DE; Sahm F; Schrimpf D; Wiestler B; Capper D; Koelsche C; Schweizer L; Korshunov A; Jones DT; Hovestadt V; Mittelbronn M; Schittenhelm J; Herold-Mende C; Unterberg A; Platten M; Weller M; Wick W; Pfister SM; von Deimling A
Acta Neuropathol; 2015 Jan; 129(1):133-46. PubMed ID: 25427834
[TBL] [Abstract][Full Text] [Related]
25. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
[TBL] [Abstract][Full Text] [Related]
26. Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma.
Matusan-Ilijas K; Behrem S; Jonjic N; Zarkovic K; Lucin K
Pathol Oncol Res; 2008 Sep; 14(3):293-8. PubMed ID: 18493866
[TBL] [Abstract][Full Text] [Related]
27. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
28. Hsp27 and its expression pattern in diffusely infiltrating astrocytomas.
Mäkelä KS; Haapasalo JA; Ilvesaro JM; Parkkila S; Paavonen T; Haapasalo HK
Histol Histopathol; 2014 Sep; 29(9):1161-8. PubMed ID: 24599602
[TBL] [Abstract][Full Text] [Related]
29. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
[TBL] [Abstract][Full Text] [Related]
30. Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.
Rosager AM; Sørensen MD; Dahlrot RH; Hansen S; Schonberg DL; Rich JN; Lathia JD; Kristensen BW
PLoS One; 2017; 12(8):e0182954. PubMed ID: 28837569
[TBL] [Abstract][Full Text] [Related]
31. Complement activation in astrocytomas: deposition of C4d and patient outcome.
Mäkelä K; Helén P; Haapasalo H; Paavonen T
BMC Cancer; 2012 Dec; 12():565. PubMed ID: 23199209
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of invasiveness of astrocytoma using 1H-magnetic resonance spectroscopy: correlation with expression of matrix metalloproteinase-2.
Zhang K; Li C; Liu Y; Li L; Ma X; Meng X; Feng D
Neuroradiology; 2007 Nov; 49(11):913-9. PubMed ID: 17763847
[TBL] [Abstract][Full Text] [Related]
34. The role of FilGAP, a Rac-specific Rho-GTPase-activating protein, in tumor progression and behavior of astrocytomas.
Hara A; Hashimura M; Tsutsumi K; Akiya M; Inukai M; Ohta Y; Saegusa M
Cancer Med; 2016 Dec; 5(12):3412-3425. PubMed ID: 27790861
[TBL] [Abstract][Full Text] [Related]
35. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.
Rickman DS; Bobek MP; Misek DE; Kuick R; Blaivas M; Kurnit DM; Taylor J; Hanash SM
Cancer Res; 2001 Sep; 61(18):6885-91. PubMed ID: 11559565
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of astrocyte elevated gene-1 in human astrocytomas.
He Z; He M; Wang C; Xu B; Tong L; He J; Sun B; Wei L; Chu M
Int J Clin Exp Pathol; 2014; 7(8):5038-44. PubMed ID: 25197376
[TBL] [Abstract][Full Text] [Related]
37. Cellular proliferation in pilocytic and diffuse astrocytomas.
Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
[TBL] [Abstract][Full Text] [Related]
39. Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma.
Tanizaki Y; Sato Y; Oka H; Utsuki S; Kondo K; Miyajima Y; Nagashio R; Fujii K
Pathol Int; 2006 Sep; 56(9):510-5. PubMed ID: 16930331
[TBL] [Abstract][Full Text] [Related]
40. Differential expression between pilocytic and anaplastic astrocytomas: identification of apolipoprotein D as a marker for low-grade, non-infiltrating primary CNS neoplasms.
Hunter S; Young A; Olson J; Brat DJ; Bowers G; Wilcox JN; Jaye D; Mendrinos S; Neish A
J Neuropathol Exp Neurol; 2002 Mar; 61(3):275-81. PubMed ID: 11895042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
